Cyproheptadine hydrochloride
(ZPMVNZLARAEGHB-UHFFFAOYSA-N)
Structure
- SMILES
- CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1.Cl
- Molecular Formula:
- C21H22ClN
- Molecular Weight:
- 323.859
- Log P:
- 5.4378
- Hydrogen Bond Acceptor:
- 1
- Hydrogen Bond Donor:
- 1
- TPSA:
- 3.24
- CAS Number(s):
- 969-33-5; 6032-06-0; 41354-29-4
Synonym(s)
1.
Cyproheptadine hydrochloride
2.
Hydron;1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;chloride
3.
1-Methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidin-1-ium;chloride
External Link(s)
| PubChem Compound | 43834424 657241 13770 |
| ChEBI | 59695 |
| CHEMBL | CHEMBL1716 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Delirium | FAERS: 3 | US FAERS | |
| 2 | Mydriasis | FAERS: 3 | US FAERS | |
| 3 | Sinus Tachycardia | FAERS: 3 | US FAERS | |
| 4 | Drug ineffective | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Somnolence | FAERS: 2 | US FAERS | |
| 6 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 7 | Vomiting | FAERS: 2 | US FAERS | |
| 8 | Acute respiratory failure | FAERS: 1 | US FAERS | |
| 9 | Adverse event | FAERS: 1 | US FAERS | |
| 10 | Anxiety | FAERS: 1 | US FAERS | |
| 11 | Burkholderia cepacia complex infection | FAERS: 1 | US FAERS | |
| 12 | Disease recurrence | FAERS: 1 | US FAERS | |
| 13 | Drooling | FAERS: 1 | US FAERS | |
| 14 | Drug Dependence | FAERS: 1 | US FAERS | |
| 15 | Dysarthria | FAERS: 1 | US FAERS | |
| 16 | Dysgeusia | FAERS: 1 | US FAERS | |
| 17 | Emotional disorder | FAERS: 1 | US FAERS | |
| 18 | Headache | FAERS: 1 | US FAERS | |
| 19 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 20 | Lethargy | FAERS: 1 | US FAERS | |
| 21 | Myoclonus | FAERS: 1 | US FAERS | |
| 22 | Nausea | FAERS: 1 | US FAERS | |
| 23 | Obsessive-Compulsive Disorder | FAERS: 1 | US FAERS | |
| 24 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 25 | Serotonin Syndrome | FAERS: 1 | US FAERS | |
| 26 | Suicide attempt | FAERS: 1 | US FAERS | |
| 27 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 28 | nervous system disorder | FAERS: 1 | US FAERS | |
| 29 | Product substitution issue | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.